Full Breakdown
Trump and Mark Cuban Team on Expanded TrumpRx Initiative
5/20/2026, 11:42:44 AM
TrumpRx Expansion Announced
On May 18, 2026, President Donald Trump announced an expansion of TrumpRx.gov, adding 600 generic medications. The rollout paired the administration with Mark Cuban’s Cost Plus Drugs, Amazon Pharmacy and GoodRx. Trump said the catalog grew “nearly seven times” and that generics would be sold at “a tiny fraction” of branded prices. Cuban described the partnership as a bipartisan effort to lower drug costs.
Prescription-Drug Cost Context
U.S. drug prices are about three times those of peer nations. PBMs control roughly 80 % of prescriptions and retain rebates equal to 42 % of brand-drug spending. Cost Plus Drugs sells generics at cost plus a 15 % markup, a $5 dispensing fee and $5 shipping; Imatinib falls from $2,000 to $17. The TrumpRx expansion lifts the generic catalog to 600, with White House estimates of $529 billion in savings over ten years.
Statements from Trump, Cuban, and Officials
Trump said, “I’m thrilled to announce that we’re increasing the number of drugs available on TrumpRx by nearly seven times.” Cuban said he had been a leading proponent of the platform and emphasized that Democrats also want cheaper medications. Spokesman Kush Desai called Joy Behar’s on-air criticism “an idiot.” Senator Elizabeth Warren disputed Trump’s 600 % price-cut claim.
Criticism & Opposition
Joy Behar warned, “you lie down with dogs, you wake up with fleas,” saying Trump’s name on prescriptions could be harmful. Hostin called him “not a well-intentioned person.” Griffin noted the drugs lack Trump’s name and cited Scandinavian national health insurance as a contrast. Analysts said the platform may aid uninsured patients but offers limited discounts for those with comprehensive coverage, leaving brand drugs excluded.
Conflicting Reports & Gaps
The White House projects $529 billion in savings, yet analysts say the program offers modest discounts for insured patients and may not affect many high-price brand drugs. Trump’s 600 % price-cut claim is disputed by Senator Warren. A New York Times review found TrumpRx prices twice those in comparable wealthy nations, suggesting limited transparency for brand-drug pricing.
Outlook
The administration plans to keep adding generics, monitor price outcomes, and evaluate consumer impact. Lawmakers have signaled interest in reviewing PBM practices, and both Trump and Cuban have indicated they will continue collaborating on affordable-drug initiatives.
Verbatim Quotes
- “First of all, you lie down with dogs, you wake up with fleas,” — Joy Behar, co-host, *The View*
- “The drugs don’t actually have his name,” — Alyssa Farah Griffin, co-host, *The View*
- “Well, he made a mistake. It was a big mistake.” — Donald Trump, President of the United States
- “I think other than you, I've been the biggest proponent of TrumpRx.com,” — Mark Cuban, entrepreneur